Published: 2018-12-09

Articles

Do Prior Authorization Policies Discourage First-Line Antipsychotic Use in Patients Newly Discharged from a Hospitalization for Schizophrenia in Saskatchewan?

David F Blackburn, David Tran, Alex Crawley, Sarah Lynds, Anne Champagne, Lauren Bresee
Abstract 160 | PDF Downloads 97

Canada's Progress Toward an Orphan Drug Framework: 2014

Stuart MacLeod
Abstract 197 | PDF Downloads 94

An Orphan Drug Framework (ODF) for Canada

David K Lee, Barbara Wong
Abstract 409 | PDF Downloads 368

Redefining Cancer: A New Paradigm for Better and Faster Treatment Innovation

David J Stewart, Gerald Batist
Abstract 279 | PDF Downloads 129

A New Toolkit for Conducting Clinical Trials in Rare Disorders

Lusine Abrahamyan, Ivan R Diamond, Sindhu R Johnson, Brian M Feldman
Abstract 226 | PDF Downloads 193

A New Toolkit for Conducting Clinical Trials in Rare Disorders: Will This Dog Hunt?

Robert G Peterson, Stuart M MacLeod, Agnes V Klein
Abstract 144 | PDF Downloads 122

The Differential Diagnosis of Fetal Alcohol Spectrum Disorder

Tom Leibson, Gal Neuman, Albert E Chudley, Gideon Koren
Abstract 2247 | PDF Downloads 1580

Validation of the Photographic Method in Fetal Alcohol Spectrum Disorder Screening and Diagnosis

Marina Avner, Paul Henning, Gideon Koren, Irena Nulman
Abstract 476 | PDF Downloads 351